State Ledger
Company profile

Protalix BioTherapeutics, Inc. CIK 1006281

Ticker
PLX (NYSE)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Hackensack, NJ 07601
Fiscal year end
2025 (FY)
Market Data
Close
$2.78
Change
+$0.01
Change %
0.18%
Volume
62,668

PLX · trading date Oct 12, 2026 · previous close $2.78 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$52.74M
Net income
-$6.60M
Total assets
$82.35M
Total liabilities
$34.12M
Stockholders' equity
$48.23M
Cash & equivalents
$14.68M
Operating income
-$5.50M
Operating cash flow
-$11.99M
Capital expenditures
$1.64M

Fiscal year 2025, via 10-K filed 2026-03-18. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-10.4%
Net margin
-12.5%
Free cash flow
-$13.63M
Free cash flow margin
-25.8%
Liabilities / assets
41.4%
Equity / assets
58.6%
CapEx / revenue
3.1%
Operating cash flow / net income
1.82×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $52.74M -$6.60M $82.35M $34.12M $48.23M
2024 $53.40M $2.93M $73.42M $30.21M $43.21M
2023 $65.49M $8.31M $84.43M $50.87M $33.57M
2022 $47.64M -$14.93M $55.79M $66.43M -$10.64M
2021 $38.35M -$27.58M $73.67M $79.70M -$6.04M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-09
Financials filed via
Form 10-K
filed 2026-03-18

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Hackensack, NJ 07601
2 UNIVERSITY PLAZA
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:39 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies